Status:
COMPLETED
Preclinical Validation of New Anti-melanoma Compounds
Lead Sponsor:
Centre Hospitalier Universitaire de Nice
Conditions:
Melanoma
Eligibility:
All Genders
18+ years
Brief Summary
This research program is in keeping with the chemistry/biology/clinical interface and gathers 4 teams with complementary expertise in these respective fields. It will allow deciphering the mechanism(s...
Eligibility Criteria
Inclusion
- Patient with metastatic melanoma
- Not opposition of the patient will have been looked for
Exclusion
- Primary resistance,
- Absence of resistance,
- Patient already included in other trials
Key Trial Info
Start Date :
February 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 31 2021
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT03798977
Start Date
February 1 2018
End Date
July 31 2021
Last Update
February 6 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nice hospital
Nice, France, 06000